.png)
.png)
The pandemic has no doubt created lots of shortages in our supply chain, including materials used in the manufacturing process of various drugs. Due to the complicated supply chain, manufacturers came to face with back orders of supplies, such as glass vials, stoppers, sterile filters, single use systems, etc.
During this session, we will present some examples how pharmaceutical industry is coping with supply shortages and managing their supply chain to avoid or minimize drug shortages. Also, hear how Quality Risk Management can play a role in handling supply chain disruptions. Additionally, representatives from multiple product Centers will be available to address how each Center communicates or assists manufacturers with their non-ingredient supply shortage.
Mai X. Huynh, MS
Supervisory Chemist, CVM
U.S. FDA
Silver Spring, Maryland, United States
Tiffany A. Baker, MBA
Consultant
ValSource Inc.
Providence, Rhode Island, United States
Renée S. Blosser, MS
Microbiologist, CVM
U.S. FDA
Rockville, Maryland, United States
.jpg "Patricia F. Hughes, PhD photo")
Patricia F. Hughes, PhD
Senior Scientific Advisor, CDER
U.S. FDA
Silver spring, Maryland, United States